Gordofilm Wart Remover Recalled Due to Manufacturing Deviations
Gordofilm Wart Remover by Gordon Laboratories is being recalled nationwide due to Current Good Manufacturing Practice (cGMP) deviations. The FDA classified this as a Class II recall on May 13, 2024.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall initiated voluntarily due to Current Good Manufacturing Practice deviations. No illnesses, injuries, or hospitalizations are reported in the source. As a voluntary, precautionary recall without documented harm, it meets the Moderate severity category.
Plain-English summary
Gordofilm Wart Remover (salicylic acid 16.7% USP) in 15 cc glass jars has been recalled nationwide. The recall was initiated by the manufacturer, Dercher Enterprises, Inc., doing business as Gordon Laboratories of Upper Darby, Pennsylvania, due to Current Good Manufacturing Practice (cGMP) deviations.
The recall affects 5,247 glass jars with the following lot codes: Lot #F135 (expiration March 2025), Lot #F146 (expiration April 2025), Lot #G103 (expiration January 2026), and Lot #G194 (expiration September 2026). These products were distributed nationwide within the United States.
The FDA classified this as a Class II recall on May 13, 2024. This is a voluntary recall initiated by the firm on April 12, 2024.
The recalled product
- Product
- Gordofilm Wart Remover (salicylic acid 16.7% USP) packaged in 15 cc glass jars, Gordon Laboratories, Upper Darby PA 19082, NDC 10481-3009-01
- Manufacturer
- Dercher Enterprises, Inc., DBA Gordon Laboratories
- Hazard
- gmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lot #: F135
- Exp. Date March 2025
- F146
- Exp. Date April
- 2025
- G103
- Exp. Date January 2026
- G194
- Exp. Date September 2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27